MichelleReinhardtPharmD, BCPP(She/Her)

Summary

• Michelle Reinhardt, PharmD, BCPP is the Chief Scientific Officer at 406 Recovery. She has practiced as a board-certified psychiatric pharmacist (BCPP) in Montana since 2014. She graduated with her Doctor of Pharmacy (PharmD) degree from Roseman University in Southern Nevada, and then went on to complete residency in Clinical Pharmacy at Billings Clinic and in Psychopharmacology at The University of Texas, Austin.
  
  After finishing residency, she joined Billings Clinic and founded the organization’s first inpatient psychopharmacology service line, working alongside other psychiatric providers to ensure evidence-based, safe, and effective patient-specific treatment for individuals with mental health and substance use disorders. She was a founding-member of Project ECHO Billings Clinic and participated in interdisciplinary education and training to Montana-based healthcare providers across the state. She later joined the University of Washington Psychiatry Residency – Montana Track faculty, and provided psychopharmacology education, training and supervision to PGY 3 & 4 resident psychiatrists.
  
  Her professional interests include evidence-based psychopharmacology, pharmacokinetics, pharmacodynamics, pharmacogenetics and interdisciplinary education of residents and students. She is board certified in psychopharmacology through the American Association of Psychiatric Pharmacists (AAPP).